Results 31 to 40 of about 1,232,473 (312)

Cytogenetic study of type 2 diabetes mellitus

Wasit Journal for Pure Sciences, 2022
Type 2 of diabetic mellitus (DM) is characterized by chronic hyperglycemia with abnormalities of fat and protein metabolism resulting from defects in insulin secretion, insulin action or both.
Zafir Hassan Ghali , Noor Jamal Hussein
doaj   +1 more source

Type 2 Diabetes Risk Alleles Are Associated With Reduced Size at Birth [PDF]

, 2009
OBJECTIVE: Low birth weight is associated with an increased risk of type 2 diabetes. The mechanisms underlying this association are unknown and may represent intrauterine programming or two phenotypes of one genotype.
Timpson, NJ, Ruokonen, A, Weedon, Michael N, Hattersley, AT, McCarthy, MI, Pouta, Anneli, Lindgren, Cecilia M, Perry, JR, Weedon, MN, Elliott, P, Groves, Christopher J, Smith, GD, Shields, B, Power, C, Järvelin, MR, Hyppönen, E, Shields, Beverley, Zeggini, Eleftheria, McCarthy, Mark I, Bennett, Amanda J, Ring, Susan M, Power, Chris, Ring, SM, Ruokonen, Aimo, Pouta, A, Strachan, DP, Elliott, Paul, Järvelin, Marjo-Riitta, Timpson, Nicholas J, Lango, Hana, Groves, CJ, Bennett, AJ, Hattersley, Andrew T, Lindgren, CM, Smith, George Davey, Zeggini, E, Frayling, Timothy M, Strachan, David P, Lango, H, Hyppönen, Elina, Freathy, RM, Perry, John R B, Frayling, TM, Freathy, Rachel M   +43 more
core   +1 more source

Epidemiology, genetic landscape and classification of childhood diabetes mellitus in the State of Qatar

Journal of Diabetes Investigation, 2021
Aims/Introduction To study the epidemiology, genetic landscape and causes of childhood diabetes mellitus in the State of Qatar. Materials and methods All patients (aged 0–18 years) with diabetes mellitus underwent biochemical, immunological and genetic ...
Basma Haris, Saras Saraswathi, Sara Al‐Khawaga, Reem Hasnah, Amira Saeed, Shihab Mundekkadan, Noor Hamed, Houda Afyouni, Tasneem Abdel‐Karim, Shayma Mohammed, Amel Khalifa, Maryam Al‐Maadheed, Mahmoud Al‐Zyoud, Ahmed Shamekh, Ahmed Elawwa, Fawziya Al‐Khalaf, Sabri Boughorbel, Goran Petrovski, Khalid Hussain   +18 more
doaj   +1 more source

Adding pioglitazone to insulin containing regimens in type 2 diabetes : systematic review and meta-analysis [PDF]

, 2009
Background Type 2 diabetes is treated in a stepwise manner, progressing from diet and physical activity to oral antidiabetic agents and insulin. The oral agent pioglitazone is licensed for use with insulin when metformin is contraindicated or not ...
Waugh Norman, Christine Clar, Clar Christine, Waugh, Norman, Norman Waugh, Royle Pamela, Clar, C., Royle, Pamela, Pamela Royle   +8 more
core   +1 more source

TREATMENT OF TYPE 2 DIABETES MELLITUS

Medical Clinics of North America, 1998
Although most patients with type 2 diabetes mellitus can be initially managed with diet and exercise alone, most eventually require at least oral agents if not insulin to maintain glycemic control. Appropriate therapeutic regimens may be difficult to design, given the diversity of drugs available for clinical use.
Feinglos, M, Bethel, M
openaire   +2 more sources

Dyslipidemia in Type 2 Diabetes mellitus

Journal of Pathology of Nepal, 2017
Background: In type 2 diabetes mellitus lipid abnormalities are very common and is associated with increased risk of cardiovascular diseases.  This study was conducted to find association of type 2 diabetes and dyslipidemia.Materials and Methods: This ...
Subarna Dhoj Thapa, Shiva Raj K.C, Santosh Gautam, Deepika Gyawali   +3 more
doaj   +1 more source

Association of time in range with hemoglobin A1c, glycated albumin and 1,5‐anhydro‐d‐glucitol

Journal of Diabetes Investigation, 2021
Aims/Introduction Hemoglobin A1c (HbA1c), glycated albumin (GA) and 1,5‐anhydro‐d‐glucitol (1,5‐AG) are used as indicators of glycemic control, whereas continuous glucose monitoring (CGM) is used to assess daily glucose profiles.
Mana Ohigashi, Keiko Osugi, Yoshiki Kusunoki, Kahori Washio, Satoshi Matsutani, Taku Tsunoda, Toshihiro Matsuo, Kosuke Konishi, Tomoyuki Katsuno, Mitsuyoshi Namba, Hidenori Koyama   +10 more
doaj   +1 more source

Glucagon-like peptide analogues for type 2 diabetes mellitus : systematic review and meta-analysis [PDF]

, 2010
Background Glucagon-like peptide (GLP-1) analogues are a new class of drugs used in the treatment of type 2 diabetes. They are given by injection, and regulate glucose levels by stimulating glucose-dependent insulin secretion and biosynthesis ...
Deepson S Shyangdan, Christine Clar, Pawana Sharma, Royle, Pamela L, Sharma Pawana, Royle Pamela L, Clar, Christine, Clar, C., Waugh, Norman R, Waugh Norman R, Pamela L Royle, Shyangdan Deepson S, Clar Christine, Waugh, Norman, Norman R Waugh, Sharma, Pawana, Shyangdan, D. (Deepson), Shyangdan, Deepson S, Royle, Pamela   +18 more
core   +1 more source

Diabetes mellitus type 2 in urban Ghana: characteristics and associated factors. [PDF]

, 2012
BACKGROUND: Sub-Saharan Africa faces a rapid spread of diabetes mellitus type 2 (DM2) but its potentially specific characteristics are inadequately defined.
Spranger, J, Micah Frank, Bedu-Addo George, Mockenhaupt Frank P, Karl-Johann Terpe, Bedu-Addo, G, Ekkehart Dietz, Frank Micah, Amoako, YA, Ina Danquah, van der Giet, M, van der Giet Markus, Awuku Yaw A, Dietz, E, Micah, F, Yaw A Amoako, Terpe, KJ, Awuku, YA, Danquah, I, Mockenhaupt, FP, Danquah Ina, Joachim Spranger, Amoako Yaw A, George Bedu-Addo, Terpe Karl-Johann, Spranger Joachim, Markus van der Giet, Frank P Mockenhaupt, Dietz Ekkehart, Yaw A Awuku   +29 more
core   +1 more source

Type 2 diabetes mellitus and bone [PDF]

Journal of Internal Medicine, 2018
AbstractType 2 diabetes (T2DM) is a rapidly growing public health problem. It is associated with an increased risk of fracture, particularly of the hip, despite normal or high bone mineral density. Longer duration of disease and poor glycaemic control are both associated with higher fracture risk. The factors underlying increased fracture risk have not
openaire   +2 more sources